Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Which Sp 500 Fund Has Lowest Expense Ratio For Retirement
Compare expense ratios across Sp 500 funds to find Which Sp 500 Fund Has Lowest Expense Ratio For Retirement and keep more of your money working for you.
28,047 articles
January Pharmacy Network Shuffle Upends Medicare Plans
A yearly reshuffle of Medicare Part D pharmacy networks can swing out-of-pocket costs for maintenance meds. Investors...
What Best Energy Stocks to Own for the Next Decade
Electricity demand is rising fast, and this shifts the playing field for energy stocks. Learn how to identify what be...
Talkspace Stock Surged Today: Drivers Behind the Jump
Talkspace stock surged today as investors responded to stronger-than-expected results and improving unit economics. T...
India’s Impact Summit Closes with New Delhi Declaration
New Delhi hosted a five-day AI summit that culminated in the New Delhi Declaration and a $200 billion investment pled...
Lowe’s Stumbles on Weak Guidance as TJX Climbs on Beat
Lowe’s beat on near-term earnings but issued a muted FY26 outlook, sending its stock lower while TJX jumped on strong...
Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
X Warns Against Creator Payouts Over AI War Videos
When AI generated war videos appear without disclosure, monetization can vanish. This piece explains what Xs warning ...
Rise of Combat Drones Rewriting Modern Warfare Rules
A new generation of unmanned systems is changing strategy and markets alike. Investors are watching how the rise comb...
Palo Alto Networks Just Made a $25B Bet on One Platform
When a cybersecurity giant bets $25 billion on a single platform, investors should understand the why, the potential ...
Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status